ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT
Square J 5 – Mannheim – 68159
VAT: DE143845625
http://www.zi-mannheim.de
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT has received € 2,781,597.0 for its participation in a total of 2 project(s) with a total cost of € 121,201,508.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-01-01 | 668863 | SyBil-AA | pharmaceutical drugs · cardiovascular diseases · personalized medicine · alcohols · magnetic resonance imaging | 2019-12-31 | coordinator | € 1,861,352.5 | € 5,759,923 | 2 | 16 | CORDIS ↪ |
| 2018-06-01 | 777394 | AIMS-2-TRIALS | epilepsy · personalized medicine | 2025-05-31 | participant | € 920,245.0 | € 115,441,584 | 1 | 57 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT has received € 2,350,000.0 for its participation in a total of 1 project(s) with a total cost of € 10,000,000.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-01 | 101071777 | OxytocINspace | anatomy and morphology · cell signaling · geometry · mammalogy | 2029-05-31 | coordinator | € 2,350,000.0 | € 10,000,000 | 4 | 6 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT has received € 2,555,021.0 for its participation in a total of 4 project(s) with a total cost of € 55,660,326.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2008-08-01 | 211696 | LIPIDIDIET | alzheimer · lipids · nutrition | 2015-03-31 | participant | € 50,973.6 | € 7,995,577 | 1 | 19 | CORDIS ↪ |
| 2012-01-01 | 278948 | TACTICS | obsessive-compulsive disorder · proteomics · substance abuse · paediatrics · machine learning | 2018-06-30 | participant | € 383,480.0 | € 7,914,883 | 1 | 12 | CORDIS ↪ |
| 2009-09-01 | 115008 | NEWMEDS | drug discovery · cognitive neuroscience · pharmaceutical drugs · schizophrenia · machine learning | 2015-02-28 | participant | € 1,149,873.0 | € 24,849,675 | 1 | 20 | CORDIS ↪ |
| 2010-02-01 | 242114 | OPTIMISE | drug discovery · schizophrenia | 2016-07-31 | participant | € 970,695.0 | € 14,900,190 | 1 | 23 | CORDIS ↪ |